ALGN
Align Technology, Inc. · Healthcare · Medical - Devices
Momentum inputs (comparable managers):
holder breadth -5.0% ·
share flow -0.5% ·
net new positions -5.3%
· formula
Broad distribution: falling shares and fewer holders
All ownership figures: tracked 13F managers only, common-stock positions, reporting period Q2 2025
| Quarter | Holders | Δ | Shares | Reported value | New | Exits |
|---|---|---|---|---|---|---|
| Q3 2026 | 4 | 0 | 3.13M | $454.47M | n/a | −2 |
| Q2 2026 | 152 | -2 | 56.51M | $9.53B | +4 | −7 |
| Q1 2026 | 158 | -3 | 53.10M | $9.09B | +1 | −5 |
| Q4 2025 | 160 | -1 | 51.76M | $8.08B | +1 | −1 |
| Q3 2025 | 23 | +2 | 27.57M | $3.45B | +3 | −2 |
| Q2 2025 | 19 | -1 | 27.12M | $5.13B | +1 | −2 |
| Q1 2025 | 17 | 0 | 12.53M | $1.99B | +2 | −2 |
| Q4 2024 | 17 | 0 | 12.70M | $2.65B | n/a | n/a |
| Q3 2024 | 16 | -2 | 10.06M | $2.56B | n/a | −2 |
| Q2 2024 | 18 | n/a | 8.21M | $1.98B | n/a | n/a |
| # | Manager | Shares | Δ shares | Value | Their weight | Held | ||
|---|---|---|---|---|---|---|---|---|
| 1 | The Vanguard Group ✦ (passive) | 8.24M | n/a | $1.56B | 0.0% | n/c | 1 | SEC ↗ ×6 |
| 2 | BlackRock ✦ (passive) | 5.13M | n/a | $970.74M | 0.0% | n/c | 1 | SEC ↗ ×22 |
| 3 | State Street Global Advisors ✦ (passive) | 2.93M | -2.2% | $554.24M | 0.0% | ▼ Trim | 3 | SEC ↗ |
| 4 | Wellington Management ✦ | 2.17M | +6.6% | $409.99M | 0.1% | ▲ Add | 5 | SEC ↗ ×8 |
| 5 | Geode Capital Management ✦ (passive) | 1.78M | -3.9% | $336.48M | 0.0% | ▼ Trim | 5 | SEC ↗ ×2 |
| 6 | Citadel Advisors ✦ | 1.67M | +3.9% | $316.85M | 0.3% | ▲ Add | 5 | SEC ↗ ×2 |
| 7 | Fidelity (FMR) ✦ | 1.34M | n/a | $254.51M | 0.0% | n/c | 1 | SEC ↗ ×3 |
| 8 | Capital World Investors ✦ | 1.30M | +3.6% | $245.54M | 0.0% | ▲ Add | 5 | SEC ↗ |
| 9 | Norges Bank ✦ (passive) | 820.24K | -6.6% | $155.30M | 0.0% | ▼ Trim | 5 | SEC ↗ |
| 10 | Millennium Management ✦ | 753.49K | -16.0% | $142.66M | 0.1% | ▼ Trim | 5 | SEC ↗ |
| 11 | AQR Capital Management ✦ | 532.14K | +31.6% | $100.75M | 0.1% | ▲ Add | 5 | SEC ↗ ×5 |
| 12 | Adage Capital Partners ✦ | 161.81K | +27.0% | $30.64M | 0.1% | ▲ Add | 5 | SEC ↗ |
| 13 | T. Rowe Price ✦ | 101.65K | +0.4% | $19.25M | 0.0% | ▲ Add | 5 | SEC ↗ ×2 |
| 14 | Arrowstreet Capital ✦ | 63.50K | +189.1% | $12.02M | 0.0% | ▲ Add | 2 | SEC ↗ |
| 15 | Gotham Asset Management ✦ | 60.25K | +43.4% | $11.41M | 0.1% | ▲ Add | 5 | SEC ↗ |
| 16 | Fisher Asset Management ✦ | 52.89K | -8.1% | $10.01M | 0.0% | ▼ Trim | 5 | SEC ↗ |
| 17 | ARK Investment Management ✦ | 6.21K | +3.7% | $1.17M | 0.0% | ▲ Add | 5 | SEC ↗ |
| 18 | Bridgewater Associates ✦ | 2.26K | -23.8% | $428,454 | 0.0% | ▼ Trim | 5 | SEC ↗ |
| 19 | Renaissance Technologies ✦ | 2.10K | New | $397,593 | 0.0% | New | 1 | SEC ↗ |
“Their weight” = the position's share of that manager's reported 13F equity value: the conviction measure. ✦ = curated manager.
New buyers
| Renaissance Technologies | $397,593 | 0.0% |
Exited
| Marshall Wace | $35.03M | was 0.0% |
| D. E. Shaw & Co. | $3.88M | was 0.0% |
Full-market context: across ALL 13F filers (SEC structured data, Q1 2026): 680 holders, 68.43M shares, $11.46B reported. This is a different, older period than the tracked-universe figures above and the two are never mixed.
What else this security's tracked holders most often hold: shared-ownership counts, not fundamental relationships.